Seven obese Type 2 diabetic patients were studied for two 4-h periods after ingestion of a glucose load to determine the effects of preprandial subcutaneous injection of Insulin Lispro (5 min before the meal) or regular insulin (20 min before the meal) on glucose metabolism. Glucose production and utilisation were measured using a dual isotope method. After Lispro, the mean postprandial increase in plasma glucose was 29% lower and the increase in insulin concentration 25% higher than after regular insulin (p < 0.05). Suppression of endogenous glucose production was similar with both types of insulin. Thus, preprandial injection of Lispro reduced postprandial glucose increments in Type 2 diabetic patients as compared to regular insulin. This...
OBJECTIVE — In this study, we sought to determine whether postprandial insulin secretion, insulin ac...
ContextOverweight and obesity are overrepresented in adolescents with type 1 diabetes mellitus (T1DM...
OBJECTIVE - To investigate the effects of a multiple injection regimen with a mixture of 75% lispro ...
The loss of first-phase insulin secretion is a characteristic feature of type 2 diabetic patients. T...
金沢大学大学院医学系研究科 Objective. The optimal approach to relatively recent onset type 2 diabetes patients is...
OBJECTIVE: Insulin lispro is a rapid-acting analog of human insulin that can be used to target the p...
To determine if the more rapid absorption of subcutaneously administered human insulin, as compared ...
BACKGROUND: The use of rapid-acting insulin analogs and regular insulin differs considerably in coun...
Aims: To compare metabolic control under lispro and recombinant regular human insulin (RHI) in peopl...
grantor: University of TorontoTreatment of type 1 diabetes (T1D) with lispro insulin reduc...
Aim: To investigate the safety and efficacy of BioChaperone Lispo (BCLIS), an ultra-rapid formulatio...
Insulin pharmacokinetics is not well understood during continuous subcutaneous insulin infusion in t...
OBJECTIVE: To obtain clinically applicable data on the effects of regular human insulin and the LysB...
To investigate the effects of a multiple injection regimen with a mixture of 75% lispro and 25% inte...
Objective: This study was performed to compare in real-life conditions the serum profile of insulin ...
OBJECTIVE — In this study, we sought to determine whether postprandial insulin secretion, insulin ac...
ContextOverweight and obesity are overrepresented in adolescents with type 1 diabetes mellitus (T1DM...
OBJECTIVE - To investigate the effects of a multiple injection regimen with a mixture of 75% lispro ...
The loss of first-phase insulin secretion is a characteristic feature of type 2 diabetic patients. T...
金沢大学大学院医学系研究科 Objective. The optimal approach to relatively recent onset type 2 diabetes patients is...
OBJECTIVE: Insulin lispro is a rapid-acting analog of human insulin that can be used to target the p...
To determine if the more rapid absorption of subcutaneously administered human insulin, as compared ...
BACKGROUND: The use of rapid-acting insulin analogs and regular insulin differs considerably in coun...
Aims: To compare metabolic control under lispro and recombinant regular human insulin (RHI) in peopl...
grantor: University of TorontoTreatment of type 1 diabetes (T1D) with lispro insulin reduc...
Aim: To investigate the safety and efficacy of BioChaperone Lispo (BCLIS), an ultra-rapid formulatio...
Insulin pharmacokinetics is not well understood during continuous subcutaneous insulin infusion in t...
OBJECTIVE: To obtain clinically applicable data on the effects of regular human insulin and the LysB...
To investigate the effects of a multiple injection regimen with a mixture of 75% lispro and 25% inte...
Objective: This study was performed to compare in real-life conditions the serum profile of insulin ...
OBJECTIVE — In this study, we sought to determine whether postprandial insulin secretion, insulin ac...
ContextOverweight and obesity are overrepresented in adolescents with type 1 diabetes mellitus (T1DM...
OBJECTIVE - To investigate the effects of a multiple injection regimen with a mixture of 75% lispro ...